Clinical Development Synergies of Autologous and Allogeneic Bone Marrow Derived Cell Therapies for Ischemic Heart Failure
Time: 1:30 pm
day: Conference Day 1
Details:
- CardiAMP Cell Therapy for Ischemic HFrEF Phase III Trial
- CardiALLO NK1R+ MSC Therapy for Ischemic HFrEF Phase I/II Trial
